
# Literature Review 



### [2016_Dbhatt_Adap_Design](2016_Dbhatt_Adap_Design/)
- Bhatt, D. L., & Mehta, C. (2016). Adaptive Designs for Clinical Trials. The New England journal of medicine, 375(1), 65–74. https://doi.org/10.1056/NEJMra1510061 
<br/>

### [2021_Recurrent_Events_LEADER](2021_Recurrent_Events_LEADER/)
- Furberg, J. K., Rasmussen, S., Andersen, P. K., & Ravn, H. (2022).  Methodological challenges in the analysis of recurrent events for randomised controlled trials with application to cardiovascular events in LEADER.  Pharmaceutical statistics, 21(1), 241–267. https://doi.org/10.1002/pst.2167 
<br/>


### [2023_JACC_Gregson](2023_JACC_Gregson/)
- Gregson, J., Stone, G. W., Bhatt, D. L., Packer, M., Anker, S. D., Zeller, C., Redfors, B., & Pocock, S. J. (2023).  Recurrent Events in Cardiovascular Trials: JACC State-of-the-Art Review.  Journal of the American College of Cardiology, 82(14), 1445–1463. https://doi.org/10.1016/j.jacc.2023.07.024
<br/>


### [2025_BMC_Lee](2025_BMC_Lee/)
- Lee, S. F., Ramasundarahettige, C., Gerstein, H. C., McIntyre, W. F., Eikelboom, J., O'Donnell, M. J., Zhou, Y., Bangdiwala, S. I., & Thabane, L. (2025).  Comparison of total event analysis and first event analysis in relation to heterogeneity in cardiovascular trials.  BMC medical research methodology, 25(1), 159.  https://doi.org/10.1186/s12874-025-02593-3









